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1. Introduction 
Although the presence of heparan sulphate has 
been established in brain tissue from a variety of 
sources [l-3] , relatively little is known about the 
molecular organisation of this glycosaminoglycan in 
the central nervous system. Heparan sulphate is 
known to be synthesised by glial cells [4] and the 
accumulation of this glycosaminoglycan has been 
reported in certain mucopolysaccharidoses [5] . 
Structural studies on heparan sulphate have shown 
this glucosamineglycan to resemble heparin in that it 
contains a repeating disaccharide unit consisting of 
glucosamine and glucuronic acid [6]. Unlike heparin 
it varies in degree of N- and O-sulphated residues [7] . 
Biosynthesis studies have shown that the glycosamino- 
glycan chains are assembled attached to a polypeptide 
backbone [8]. However, heparan sulphate from brain 
tissue has always been considered to exist as discrete 
glycosaminoglycan chains. We believe that the reported 
presence of these free chains is a result of the dis- 
ruptive methods of isolation adopted by previous 
workers [l-3,9]. 
Recently we have shown the existence of a chon- 
droitin sulphate proteoglycan from ovine brain using 
a non-disruptive method of extraction [lo] . We have 
extended this study further and report here that 
heparan sulphate also exists covalently bound to a 
protein moiety. 
2. Materials and methods 
Fresh sheep brains (500 g portions) were freed 
from meninges, serous membranes and blood vessels 
and defatted by repeated extraction with chloroform/ 
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methanol (3: 1 ,v/v). The lipid-free material was 
suspended in 0.1 M citrate, pH 3.1 and gently stirred 
to remove contaminating proteins. After centrifuga- 
tion the residue was extracted by gentle stirring with 
4 M guanidinium chloride in 0.05 M Tris-HCl, 
pH 7.5,48 h at 4°C. The extract was collected and 
dialysed. On removal of the guanidinium chloride an 
insoluble residue formed (residue B) which was 
collected by centrifugation. This residue was 
repeatedly extracted with 0.1 M citrate, pH 5.0 and 
then with 0.4 M citrate, pH 5.0. The supernatant was 
collected (fraction Bn) and chromatographed on 
DEAF-cellulose (Whatman) in a linear salt-gradient 
(O-l M NaCl) in 0.4 M citrate, pH 5.0. The fractions 
collected were pooled, dialysed against 1 M potassium 
acetate, pH 7.0 and further chromatographed on 
Sepharose 4B (Pharmacia). Hexuronic acid- and 
protein-containing fractions were dialysed and then 
precipitated by the addition of ethanol and potassium 
acetate (fraction Bns). 
Amino acid content was determined on a Joel 
JLC BAH analyser. Protein was estimated from total 
amino acid concentrations and by the microbiuret 
method [ 111. Hexosamines were measured after 
hydrolysis (4 M HCl for 7 h at 100°C) by amino acid 
analysis and the modified Elson-Morgan reaction [ 121. 
N-Sulphated hexosamines were determined by the 
nitrous acid oxidation procedure [ 131. Hexuronic 
acid was measured by the carbazole reaction [ 141; 
xylose, galactose and sulphate were determined 
calorimetrically [15-l 71 . Anticoagulant activity 
was estimated by modification of the methods 
described by Sharp et al. [ 181. 
Alkali-induced p-elimination was carried out in the 
presence of disulphite ions [ 191. The solution was 
then desalted on Sephadex G-10 and the products 
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were separated by ion-exchange on DEAE-cellulose 
using a NaCl elution gradient as previously described. 
Glucosaminoglycans were degraded with nitrous acid 
by mixing a 5 mg sample with equal vol. (2 ml) 5% 
NaNOz and 33% acetic acid for 5 h at 25°C. After 
neutralisation the oxidation products were chromato- 
graphed on Sephadex G-25. Chondroitinase ABC 
(Sigma) digestion was carried out as described by 
Yamagata et al. [20]. Infrared spectra were obtained 
with KBr discs in a Unicam SP 200 spectrophoto- 
meter. 
3. Results and discussion 
It appeared from ion-exchange and gel chromato- 
graphy on 4% agarose (fig.1) that the heparan 
sulphate preparation behaved as a monodispersed 
species in which hexuronic acid- and protein-containing 
material migrated as a single peak. This fraction 
(fraction Bns) accounted for 0.8% of the total weight 
of lipid-free dry brain. 
Fraction Bns was found to be resistant to chon- 
droitinase ABC, and the only amino sugar detected 
was glucosamine. The carbohydrate moiety was 
highly sulphated, having a sulphate to glucosamine 
molar ratio of 1.8: 1. The molar proportion of 
hexuronic acid and glucosamine were found to be 
approximately equal which suggests hat the glucos- 
aminoglycan chains had not undergone any extensive 
damage during isolation (see table 1). 
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Fig.1. Elution profile of proteoheparan sulphate chromato- 
graphed on Sepharose 4B column. Fractions were assayed 
for protein (0) and hexuronic acid (0). V, and Vt of the 
column are indicated by arrows. 
It is known that nitrous acid reacts only with 
N-sulphated hexosamine r sidues to form 2,5-anhydro- 
D-mannose [21] . When the preparation was treated 
with nitrous acid two major fractions were eluted 
from a Sephadex G-25 column, fractions X and Y 
(fig.2). Fraction X, which was not retained by the 
column, was found to contain protein. However no 
anhydromannose d rivative was detected by the 
indole reaction. On amino acid analysis of this fraction 
only glucosamine was detected, with a glucosamine to
hexuronic acid molar ratio of 0.9: 1. This suggests hat 
fraction X contains a small proportion of repeating 
dissacharides in which the hexosamine r sidues are 
resistant to nitrous acid. The fraction retained by the 
column (fraction Y) was found to contain anhydro- 
mannose quivalent to 70% of the total hexosamine 
present in the original Bns preparation (fig.2). This 
implies that a large proportion of the heparan sulphate 
chains is composed of N-sulphated glucosamine. In
addition infrared analysis of the untreated Bns fraction 
revealed the presence of a strong absorption band in 
the region of 1240 cm-’ which is characteristic of
N-sulphated substitution [22]. However this absorp- 
tion was not as strong as that obtained from a sample 
of commercial heparin. 
A study of the anticoagulant activity showed that 
the sample was biologically active; 15 IU/mg compared 
to an activity of 150 IU/mg for a heparin sample. This 
value is in keeping with results obtained by other 
workers for highly sulphated heparan-sulphate species 
v31. 
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Fig.2. Gel filtration on Sephadex G-25 of the proteoheparan 
sulphate preparation (fraction Bns) after nitrous acid treat- 
ment. Fractions were analysed for hexuronic acid (0); 
2.5anhydro-D-mannose (4); protein (0). Procedures used are 
given in Materials and methods. 
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Table 1 
Amino acid analysis and chemical composition of proteoheparan sulphate (fraction Bns) 
Amino acid 
Cysteic acid 
Hydroxyproline 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Cysteine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
Chemical composition 
Untreated sample Alkali-treated sample 
- 37 
- - 
110 108 
69 73 
220 182 
102 105 
20 23 
182 176 
69 73 
63 58 
_ - 
- - 
21 20 
45 43 
11 13 
9 10 
36 32 
10 12 
33 35 
Protein Glucosamine 
12 26 
Xylose Galactose Sulphate Hexuronic acid: 
(K+ salt) Glucosamine 
(molar ratio) 
0.47 1.2 31 1.2:1 
Amino acid contents are expressed as residue/l000 residues and are corrected for hydrolytic 
losses. Chemical composition values are expressed as percentages of dry ash-free sample. 
The amino acid composition and total chemical 
composition of the proteoheparan sulphate is 
reported in table 1. Treatment of the protein moiety 
with alkali produced a 17% decrease in serine content 
with the formation of an equivalent amount of cysteic 
acid. There was no decrease in threonine which 
implies that the polysaccharide chains are linked to a 
specific serine residue within the protein backbone. 
Neutral sugar content revealed a galactose to xylose 
molar ratio of 2.1: 1. This indicates that the potential 
reducing ends of the glycosaminoglycan chains have not 
undergone degradation during the isolation procedure. 
Furthermore the amount of serine lost during alkali- 
induced @&nination accounted for 0.45% of the total 
preparation. This value is in agreement with the 
amount of xylose present in the preparation (table 1). 
Therefore, it would appear that a Ser-Xyl-Gal-Gal 
linkage region is present, which is characteristic of 
most proteoglycans [24] . 
The molecular weight of heparan sulphate has been 
estimated from a number of sources and values 
ranging from 3-170 X lo3 have been reported 
[23,25] . This particular preparation was found to 
have a glycosaminoglycan chain weight of about 
32 X lo3 as estimated from xylose concentrations. 
However, fraction Bns was found to be excluded 
from Sephadex G-100 and when further chromato- 
graphed on 4% agarose (flg.l), a Kav-value of 0.67 
was estimated [26] . Under the high ionic strength 
of the eluting buffer used, repulsive forces would be 
minimised and so the carbohydrate moiety would be 
expected to adopt a random-coil conformation. 
In conclusion we postulate that fraction Bns 
consists of a multi-chain complex in which heparan 
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sulphate is covalently bound to a common protein 
backbone. To date the possible function of this macro- 
molecule in vivo has not been established since this 
appears to be the first time that a heparan sulphate 
proteoglycan has been isolated from brain tissue. 
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